Favorable radiological antitumor response at 2 weeks after starting lenvatinib for patients with advanced hepatocellular carcinoma
- Teiji Kuzuya
- , Masatoshi Ishigami
- , Takanori Ito
- , Yoji Ishizu
- , Takashi Honda
- , Tetsuya Ishikawa
- , Mitsuhiro Fujishiro
Research output: Contribution to journal › Article › peer-review
33
Link opens in a new tab
Citations
(Scopus)